AE-Ebola

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAE-Ebola

Drug Alias NameEbola peptide vaccine (li-Key) (Antigen Express)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionHistocompatibility antigens class II modulators

TargetsHistocompatibility antigens class II

Therapy Area/IndicationsHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNugenerex Immuno-Oncology Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNugenerex Immuno-Oncology Inc

Active IndicationsN/A

Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A